Page 101 - 《中国药房》2026年4期

参考文献 [14] ZHANG Y F，ZHANG H Y，XU H Q，et al. Efficacy and
[ 1 ] BRAY F，LAVERSANNE M，SUNG H，et al. Global can‐ safety of hepatic arterial infusion chemotherapy combined
cer statistics 2022：GLOBOCAN estimates of incidence with lenvatinib and PD-1 inhibitors for advanced hepato‐
and mortality worldwide for 36 cancers in 185 countries cellular carcinoma with macrovascular invasion[J]. World
[J]. CA Cancer J Clin，2024，74（3）：229-263. J Surg Oncol，2024，22（1）：122.
[ 2 ] CHEN S M，CAO Z，PRETTNER K，et al. Estimates and [15] 卫生部 . 药品不良反应报告和监测管理办法[EB/OL].
projections of the global economic cost of 29 cancers in （2011-05-04）[2025-07-31]. http：//www. gov. cn/zhengce/
204 countries and territories from 2020 to 2050[J]. JAMA 2021-06/29/content_5723552.htm.
Oncol，2023，9（4）：465-472. [16] MOONS K G M，ALTMAN D G，REITSMA J B，et al.
[ 3 ] ZHANG M Y，ZHU J，BAO Y，et al. Bevacizumab in Transparent reporting of a multivariable prediction model
ovarian cancer therapy：current advances，clinical chal‐ for individual prognosis or diagnosis（TRIPOD）：explana‐
lenges，and emerging strategies[J]. Front Bioeng Biotech‐ tion and elaboration[J]. Ann Intern Med，2015，162（1）：
nol，2025，13：1589841. W1-W73.
[ 4 ] MAO C L，SEOW K M，CHEN K H. The utilization of be‐ [17] ZHANG N，PAN L Y，CHEN W Y，et al. A risk-factor
vacizumab in patients with advanced ovarian cancer：a sys‐ model for antineoplastic drug-induced serious adverse
tematic review of the mechanisms and effects[J]. Int J Mol events in cancer inpatients：a retrospective study based on
Sci，2022，23（13）：6911. the global trigger tool and machine learning[J]. Front Phar‐
[ 5 ] MENG X，WU Y Z，LIU Z X，et al. Active monitoring of macol，2022，13：896104.
antifungal adverse events in hospitalized patients based on [18] LUNDBERG S M，LEE S I. A unified approach to inter‐
global trigger tool method[J]. Front Pharmacol，2024，15： preting model predictions[J]. NeurIPS，2017，30：4765-
1322587. 4774.
[ 6 ] WU S，YIN Q N，WU L Y，et al. Establishing a trigger [19] LIMA S I V C，MARTINS R R，SALDANHA V，et al. De‐
tool based on global trigger tools to identify adverse drug velopment and validation of a clinical instrument to pre‐
events in obstetric inpatients in China[J]. BMC Health dict risk of an adverse drug reactions in hospitalized pa‐
Serv Res，2024，24（1）：72. tients[J]. PLoS One，2020，15（12）：e0243714.
[ 7 ] LIU Y，LIU X J，XIA B B，et al. The application of global [20] ZHENG Z L，ZHAO Y H，XIE J W，et al. Clinical risk fac‐
trigger tool in monitoring antineoplastic adverse drug tors of bevacizumab-related hypertension in patients with
events：a retrospective study[J]. Front Oncol，2024，14： metastatic colorectal cancer：a retrospective study[J].
1230514. Front Pharmacol，2024，15：1463026.
[ 8 ] GARCIA J，HURWITZ H I，SANDLER A B，et al. Beva‐ [21] ROUSSEAU A，GÉRAUD A，GEISS R，et al. Safety of
cizumab（avastin ）in cancer treatment：a review of 15 solid oncology drugs in older patients：a narrative review
®
years of clinical experience and future outlook[J]. Cancer [J]. ESMO Open，2024，9（11）：103965.
Treat Rev，2020，86：102017. [22] MOHAMMED T，SINGH M，TIU J G，et al. Etiology and
[ 9 ] PATEL J N，JIANG C，OWZAR K，et al. Pharmacoge‐ management of hypertension in patients with cancer[J].
netic and clinical risk factors for bevacizumab-related gas‐ Cardiooncology，2021，7（1）：14.
trointestinal hemorrhage in prostate cancer patients treated [23] KIM J M，JUNG H，KWON H E，et al. Predicting prog‐
on CALGB 9040：alliance [J]. Pharmacogenomics J，2024， nostic factors in kidney transplantation using a machine
24（2）：6. learning approach to enhance outcome predictions：a retro‐
[10] 徐宏珍，陈嘉，廖倩倩，等 . 基于 CHPS 系统主动监测对 spective cohort study[J]. Int J Surg，2024，110（11）：7159-
贝伐珠单抗不良反应发生特点及相关性回顾性分析[J]. 7168.
中文科技期刊数据库（引文版）医药卫生，2024（5）： [24] GENG Z，YANG C Y，ZHAO Z Y，et al. Development
65-68. and validation of a machine learning-based predictive
[11] 丁年羊，李莉，方攀奇，等. 我院贝伐珠单抗生物类似药 model for assessing the 90-day prognostic outcome of pa‐
与原研药相关不良反应回顾性分析[J]. 中国药房，2024， tients with spontaneous intracerebral hemorrhage[J]. J
35（4）：472-475. Transl Med，2024，22（1）：236.
[12] 杨江，王明航，李建生，等. 基于改良德尔菲法的支气管 [25] LIU X Z，XIE Z L，ZHANG Y，et al. Machine learning for
哮喘急性发作风险预警因素调查表及条目筛选研究[J]. predicting in-hospital mortality in elderly patients with
中国全科医学，2022，25（35）：4425-4432. heart failure combined with hypertension：a multicenter
[13] SUN J，DENG X Y，CHEN X P，et al. Incidence of ad‐ retrospective study[J]. Cardiovasc Diabetol，2024，23
verse drug reactions in COVID-19 patients in China：an （1）：407.
active monitoring study by hospital pharmacovigilance （收稿日期：2025-08-05 修回日期：2026-01-05）
system[J]. Clin Pharmacol Ther，2020，108（4）：791-797. （编辑：张元媛）

中国药房 2026年第37卷第4期 China Pharmacy 2026 Vol. 37 No. 4 · 503 ·